The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Jay L. Hess sits on this spectrum.
This scientist: 182 publications — 42nd percentile
42% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Jay L. Hess sits on this spectrum.
This scientist: 69 D-Index — 63rd percentile
63% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Jay L. Hess is affiliated with Indiana University in the United States and has contributed to the field of medicine through research focused mainly on medical education, public health, immunology, oncology, and genetics. Their work addresses diverse topics including innovations in medical education, medical education and admissions processes, diversity and career in medicine, immunotherapy and immune responses, cancer immunotherapy and biomarkers, glioma diagnosis and treatment, and the broader impacts of health and medical research.
Several recent publications highlight Jay L. Hess's engagement in these areas. Notable papers include:
Jay L. Hess frequently collaborates with other researchers such as Paul M. Wallach, Deborah R. Birnbaum, Elizabeth Ryan, Brandon T. Pieczko, and Laura de Freitas Chama. These collaborations have resulted in multiple co-authored works, reflecting a multi-disciplinary approach particularly within medical education and oncology fields.
The primary venues for Jay L. Hess's publications include:
Jay L. Hess's research contributions predominantly fall under the broad field of medicine with specific subfields concentrating on public health, environmental and occupational health, gender studies, immunology, oncology, and genetics.
The main topics covered in their research further underline their focus on medical education innovation, diversity in medicine, cancer-related immunotherapy, and neurological cancer treatment strategies. This multidisciplinary interest supports a comprehensive approach to addressing medical education alongside emerging therapeutic modalities such as mRNA cancer vaccines.
Thomas A Milne;Scott D Briggs;Hugh W Brock;Mary Ellen Martin
Benjamin D. Yu;Jay L. Hess;Susan E. Horning;Gary A. J. Brown
Yali Dou;Thomas A. Milne;Thomas A. Milne;Alan J. Tackett;Edwin R. Smith
Christina M. Hughes;Orit Rozenblatt-Rosen;Thomas A. Milne;Terry D. Copeland
Thomas A. Milne;Christina M. Hughes;Ricardo Lloyd;Zhaohai Yang
Jay L. Hess
Dorothee Mueller;Christian Bach;Deniz Zeisig;Maria Paz Garcia-Cuellar
Jolanta Grembecka;Shihan He;Aibin Shi;Trupta Purohit
Bernd B. Zeisig;Tom Milne;María Paz García-Cuéllar;Silke Schreiner
Benjamin D. Yu;Robin D. Hanson;Jay L. Hess;Susan E. Horning
Andrew G. Muntean;Jay L. Hess
Dmitry Borkin;Shihan He;Hongzhi Miao;Katarzyna Kempinska
Fang Cao;Elizabeth C. Townsend;Hacer Karatas;Jing Xu
Robin D. Hanson;Jay L. Hess;Benjamin D. Yu;Patricia Ernst;Patricia Ernst
Altuna Akalin;Francine E. Garrett-Bakelman;Matthias Kormaksson;Jennifer Busuttil
Jay L. Hess;Benjamin D. Yu;Bin Li;Rob Hanson
Thomas A. Milne;Yali Dou;Mary Ellen Martin;Hugh W. Brock
Andrew G. Muntean;Jiaying Tan;Kajal Sitwala;Yongsheng Huang
Thomas A. Milne;Mary Ellen Martin;Hugh W. Brock;Robert K. Slany
Corrado Caslini;Zhaohai Yang;Mohamad El-Osta;Thomas A. Milne
If you think any of the details on this page are incorrect, let us know.
TU Dresden
Federal University of São Carlos
University of Tokyo
Princeton University
Necker-Enfants Malades Hospital
University of Lübeck
Rovira i Virgili University
United States Geological Survey
University of Manchester
National Institutes of Health
Scripps Research Institute
Otto-von-Guericke University Magdeburg
University of Florence
RAND Corporation
Emory University
Virginia Tech
